IRF5 and neoplasm: A functional imbalance of IRFs (e.g., IRF5 overexpressing systemic lupus erythematosus (SLE), IRF4 defects and immune dysregulation) has been shown to lead to aberrant macrophage activation and promote autoimmune diseases, chronic inflammation, and tumor progression.